TW303366B - - Google Patents

Download PDF

Info

Publication number
TW303366B
TW303366B TW082105041A TW82105041A TW303366B TW 303366 B TW303366 B TW 303366B TW 082105041 A TW082105041 A TW 082105041A TW 82105041 A TW82105041 A TW 82105041A TW 303366 B TW303366 B TW 303366B
Authority
TW
Taiwan
Prior art keywords
pyridyl
pyrimidinyl
trifluoromethyl
methyl
compound
Prior art date
Application number
TW082105041A
Other languages
English (en)
Chinese (zh)
Original Assignee
Santori Kk
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santori Kk, Shionogi & Co filed Critical Santori Kk
Application granted granted Critical
Publication of TW303366B publication Critical patent/TW303366B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TW082105041A 1992-06-25 1993-06-23 TW303366B (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16783792 1992-06-25
JP13760593A JP3288132B2 (ja) 1992-06-25 1993-06-08 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物

Publications (1)

Publication Number Publication Date
TW303366B true TW303366B (enExample) 1997-04-21

Family

ID=26470855

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082105041A TW303366B (enExample) 1992-06-25 1993-06-23

Country Status (9)

Country Link
US (1) US5424310A (enExample)
EP (1) EP0576251B1 (enExample)
JP (1) JP3288132B2 (enExample)
KR (1) KR100299396B1 (enExample)
AU (1) AU658306B2 (enExample)
BR (1) BR9302641A (enExample)
CA (1) CA2098650A1 (enExample)
DE (1) DE69327074T2 (enExample)
TW (1) TW303366B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
US5747476A (en) 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
FR2866887A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation
DE102009038949A1 (de) * 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue Verwendung von heterocyclisch substituierten 1,2,4-Triazindionen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
GB1448696A (en) * 1973-05-29 1976-09-08 Pfizer 2-phqnyl-astriazine-3,4-2h,4h-diones
DE2532363A1 (de) * 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2606850A1 (de) * 1976-02-20 1977-09-15 Hoechst Ag Substituierte p-aminophenyl-as- triazindione und ihre herstellung
DE3805660A1 (de) * 1988-02-24 1989-09-07 Bayer Ag Substituierte 1,2,4-triazindione, verfahren zu ihrer herstellung und ihre verwendung
DE3814323A1 (de) * 1988-04-28 1989-11-09 Hoechst Ag Wasserloesliche zubereitungen von coccidiostatica
US5214043A (en) * 1989-01-09 1993-05-25 Bayer Aktiengesellschaft Parasiticidal substituted hexahydro-1,2,4-triazinediones
EP0377903A3 (de) * 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung

Also Published As

Publication number Publication date
DE69327074T2 (de) 2000-03-16
KR940005618A (ko) 1994-03-21
JPH0673048A (ja) 1994-03-15
US5424310A (en) 1995-06-13
EP0576251B1 (en) 1999-11-24
BR9302641A (pt) 1994-02-16
CA2098650A1 (en) 1993-12-26
JP3288132B2 (ja) 2002-06-04
DE69327074D1 (de) 1999-12-30
AU658306B2 (en) 1995-04-06
EP0576251A1 (en) 1993-12-29
AU4132693A (en) 1994-01-06
KR100299396B1 (ko) 2001-11-22

Similar Documents

Publication Publication Date Title
CN101426766B (zh) 用作mek抑制剂的杂芳基取代的芳基氨基吡啶衍生物
CN1816549B (zh) 磷脂酰肌醇3-激酶抑制剂
AU2014279116B2 (en) Amino-triazine derivatives and pharmaceutical composition containing said derivatives
US9657004B2 (en) Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
AU2013283318B2 (en) Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders
US20070149508A1 (en) Six membered heteroaromatic inhibitors targeting resistant kinase mutations
NZ546058A (en) Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors
CN102036961A (zh) 作为pi3k抑制剂的吡啶和吡嗪类化合物
CN102083822A (zh) Hedgehog信号传导的吡啶基抑制剂
US20080293940A1 (en) Amide Derivative and Medicine
SI9520084A (en) Use of heterocyclic compounds as dopamines-d3 ligands
TW200307535A (en) Therapeutic agent for cancer
CZ295346B6 (cs) Pyrimidinové sloučeniny, způsob jejich přípravy, farmaceutická kompozice a jejich použití pro léčbu poruch souvisejících s ligandy dopaminu D3
CZ292625B6 (cs) Derivát triazolu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a použití
SI9520081A (en) Use of thiazoles and thiadiazoles compounds as d3 dopamine receptor ligands.
WO2011035214A1 (en) Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
TW303366B (enExample)
JP2010524885A (ja) がん治療剤としてのナフタレンカルボン酸アミドのエーテル
WO2008150837A1 (en) Methods of treatment
CN1738615A (zh) 用作蛋白质激酶的抑制剂的二氨基三唑类
AU732722B2 (en) 2-{4-{4-(4,5-dichloro-2- methylimidazol-1-yl)butyl} -1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
RU2795572C2 (ru) Соединения и композиции для ингибирования ire1
AU759274B2 (en) 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-YL) butyl)-1-piperazinyl)-5-fluoropyrimidine, its preparation and its therapeutic use
KR20220099503A (ko) 헤테로아릴-에티닐 유도체 화합물 및 이의 용도
WO2022188792A1 (zh) 具有蛋白激酶抑制活性的杂环化合物、包含其的药物组合物及其制备方法和用途